Boston, MA, United States of America

Oliver D King

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.7

ph-index = 1


Location History:

  • Cambridge, MA (US) (2016)
  • Boston, MA (US) (2020)

Company Filing History:


Years Active: 2016-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Oliver D King: Innovator in Muscular Dystrophy Research

Introduction

Oliver D King is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of muscular dystrophy research, particularly focusing on facioscapulohumeral muscular dystrophy (FSHD). With a total of 2 patents, his work has the potential to impact the lives of many individuals affected by this condition.

Latest Patents

King's latest patents include groundbreaking inventions aimed at diagnosing and treating FSHD. The first patent, titled "Molecular diagnosis of FSHD by epigenetic signature," presents methods for determining whether an individual is at risk of developing FSHD. The second patent, "Compositions and methods for characterizing and treating muscular dystrophy," focuses on identifying new treatments for FSHD and their applications.

Career Highlights

Oliver D King is affiliated with the University of Massachusetts, where he conducts his research. His work is characterized by a commitment to advancing the understanding and treatment of muscular dystrophy. His innovative approaches have garnered attention in the scientific community.

Collaborations

King collaborates with notable colleagues, including Peter L Jones and Takako Jones. These partnerships enhance the research efforts and contribute to the development of effective treatments for muscular dystrophy.

Conclusion

In summary, Oliver D King is a dedicated inventor whose work in muscular dystrophy research is paving the way for new diagnostic and treatment methods. His contributions are vital to improving the lives of those affected by FSHD.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…